Sarepta Therapeutics (SRPT) Current Taxes (2017 - 2026)

Sarepta Therapeutics' Current Taxes history runs 8 years deep, the most recent figure standing at $13.8 million for Q1 2026.

• On a quarterly basis, Current Taxes fell 82.73% year-over-year to $13.8 million in Q1 2026; TTM through Mar 2026 was $13.8 million, a 82.73% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 72.66% from the prior year.
• Current Taxes advanced to $13.8 million in Q1 2026 per SRPT's latest filing, from $4.8 million in the prior quarter.
• Across five years, Current Taxes topped out at $79.9 million in Q1 2025 and bottomed at $4.1 million in Q3 2022.
• The 5-year median for Current Taxes is $16.1 million (2023), against an average of $19.5 million.
• Across the five-year window, Current Taxes surged 5696.76% in 2022 and plunged 82.73% in 2026, its largest moves.
• Year by year, Current Taxes stood at $12.5 million in 2022, then grew by 9.94% to $13.8 million in 2023, then advanced by 26.33% to $17.4 million in 2024, then slumped by 72.66% to $4.8 million in 2025, then surged by 189.99% to $13.8 million in 2026.
• Per Business Quant, the three latest SRPT Current Taxes figures stand at $13.8 million (Q1 2026), $4.8 million (Q4 2025), and $9.1 million (Q3 2025).